Aytu Biopharma, Inc. (AYTU)
2.56
-0.01
(-0.39%)
USD |
NASDAQ |
May 06, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
Aytu Biopharma EPS Diluted (Quarterly) : -1.055 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Illumina, Inc. | 0.8701 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.58M |
| Revenue (Quarterly) | 15.16M |
| Total Expenses (Quarterly) | 25.75M |
| Enterprise Value | 19.55M |
| Gross Profit Margin (Quarterly) | 59.99% |
| Profit Margin (Quarterly) | -69.79% |
| Earnings Yield | -149.9% |
| Normalized Earnings Yield | -116.68 |